Rufinamide
Rufinamide, an antiepileptic agent, is approved as adjunctive therapy for Lennox-Gastaut syndrome (LGS).
| Trivial name | CGP 33101; E-2080; RUF 331 |
| Catalog Number | CSN11872 |
| Alternative Name(s) | CGP 33101; E-2080; RUF 331 |
| Research Area | Neurological Disease |
| Molecular Formula | C10H8F2N4O |
| CAS# | 106308-44-5 |
| Purity | ≥99% |
| SMILES | O=C(C1=CN(CC2=C(F)C=CC=C2F)N=N1)N |
| Size | 50mg |
| Supplier Page | https://www.csnpharm.com/products/rufinamide.html |